Electrophysiology Diagnostic Catheters-Medical Devices Pipeline Assessment, 2017

Region:Global

Author(s):

Product Code:GDME0315EPD

Download Sample Report download
Buy the Full ReportStarting from $2500
Published on

March 2017

Total pages

66

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $2500

About the Report

About the Report

Electrophysiology Diagnostic Catheters-Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Electrophysiology Diagnostic Catheters-Medical Devices Pipeline Assessment, 2017" provides an overview of Electrophysiology Diagnostic Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and the number of trials for the key Electrophysiology Diagnostic Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Electrophysiology Diagnostic Catheters under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Electrophysiology Diagnostic Catheters and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to Buy

The report enables you to-

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Electrophysiology Diagnostic Catheters under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date

Products


Companies

Aust Development, LLC, Baylor College of Medicine, Boston Scientific Corp, C. R. Bard Inc, CathRx Ltd, Cordis Corp, Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon, King's College London, MicroPort Scientific Corp, The Cleveland Clinic Foundation, University of Maryland

Table of Contents

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Electrophysiology Diagnostic Catheters Overview 6

3 Products under Development 7

3.1 Electrophysiology Diagnostic Catheters-Pipeline Products by Stage of Development 7

3.2 Electrophysiology Diagnostic Catheters-Pipeline Products by Segment 8

3.3 Electrophysiology Diagnostic Catheters-Pipeline Products by Territory 9

3.4 Electrophysiology Diagnostic Catheters-Pipeline Products by Regulatory Path 10

3.5 Electrophysiology Diagnostic Catheters-Pipeline Products by Estimated Approval Date 11

4 Electrophysiology Diagnostic Catheters-Pipeline Products under Development by Companies 12

4.1 Electrophysiology Diagnostic Catheters Companies-Pipeline Products by Stage of Development 12

4.2 Electrophysiology Diagnostic Catheters-Pipeline Products by Stage of Development 13

5 Electrophysiology Diagnostic Catheters Companies and Product Overview 14

5.1 Aust Development, LLC Company Overview 14

5.1.1 Aust Development, LLC Pipeline Products & Ongoing Clinical Trials Overview 14

5.2 Baylor College of Medicine Company Overview 15

5.2.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 15

5.3 Boston Scientific Corp Company Overview 16

5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 16

5.4 C. R. Bard Inc Company Overview 17

5.4.1 C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 17

5.5 CathRx Ltd Company Overview 18

5.5.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 18

5.6 Cordis Corp Company Overview 22

5.6.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 22

5.7 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview 23

5.7.1 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview 23

5.8 King's College London Company Overview 24

5.8.1 King's College London Pipeline Products & Ongoing Clinical Trials Overview 24

5.9 MicroPort Scientific Corp Company Overview 25

5.9.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 25

5.10 The Cleveland Clinic Foundation Company Overview 28

5.10.1 The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview 28

5.11 University of Maryland Company Overview 29

5.11.1 University of Maryland Pipeline Products & Ongoing Clinical Trials Overview 29

6 Electrophysiology Diagnostic Catheters- Recent Developments 30

6.1 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 30

6.2 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 32

6.3 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 33

6.4 Jan 26, 2017: Bard Announces Fourth Quarter Results 35

6.5 Dec 28, 2016: MicroPort was selected as a pilot project of Patent Alliance of Enterprises in Shanghai Zhangjiang National Innovation Demonstration Zone 35

6.6 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 36

6.7 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 39

6.8 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 39

6.9 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 40

6.10 Oct 25, 2016: Bard Announces Third Quarter Results 42

6.11 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 42

6.12 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 44

6.13 Sep 27, 2016: MicroPort Hosts First EMEA Regional Distributor Summit 45

6.14 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 45

6.15 Aug 30, 2016: MPSC Announces 2016 Interim Results 46

6.16 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 48

6.17 Aug 05, 2016: Steerable catheter to treat cardiac arrhythmia 51

6.18 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 51

6.19 Jul 26, 2016: Bard Announces Second Quarter Results 53

6.20 Jul 22, 2016: Baylor Genetics rebrand makes debut with simplified name, targeted message 54

6.21 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results 55

6.22 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 56

6.23 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 57

6.24 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 57

6.25 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 58

6.26 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 58

6.27 Apr 01, 2016: MicroPort and Yizheng Municipal Government Establishes "Shanghai-Yizheng Healthcare Cooperation Project" 61

6.28 Mar 23, 2016: MicroPort Signs Cooperation Agreement with Beijing Weimai Medical Device 62

7 Appendix 63

7.1 Methodology 63

7.2 About GlobalData 66

7.3 Contact Us 66

7.4 Disclaimer 66


List of Figure

1.2 List of Figures

Figure 1: Electrophysiology Diagnostic Catheters-Pipeline Products by Stage of Development 7

Figure 2: Electrophysiology Diagnostic Catheters-Pipeline Products by Segment 8

Figure 3: Electrophysiology Diagnostic Catheters-Pipeline Products by Territory 9

Figure 4: Electrophysiology Diagnostic Catheters-Pipeline Products by Regulatory Path 10

Figure 5: Electrophysiology Diagnostic Catheters-Pipeline Products by Estimated Approval Date 11


List of Table

1.1 List of Tables

Table 1: Electrophysiology Diagnostic Catheters-Pipeline Products by Stage of Development 7

Table 2: Electrophysiology Diagnostic Catheters-Pipeline Products by Segment 8

Table 3: Electrophysiology Diagnostic Catheters-Pipeline Products by Territory 9

Table 4: Electrophysiology Diagnostic Catheters-Pipeline Products by Regulatory Path 10

Table 5: Electrophysiology Diagnostic Catheters-Pipeline Products by Estimated Approval Date 11

Table 6: Electrophysiology Diagnostic Catheters Companies-Pipeline Products by Stage of Development 12

Table 7: Electrophysiology Diagnostic Catheters-Pipeline Products by Stage of Development 13

Table 8: Aust Development, LLC Pipeline Products & Ongoing Clinical Trials Overview 14

Table 9: Endovascular Cardiac Optical Mapping Device-Product Status 14

Table 10: Endovascular Cardiac Optical Mapping Device-Product Description 14

Table 11: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 15

Table 12: Electrical-Anatomical Imaging Catheter-Product Status 15

Table 13: Electrical-Anatomical Imaging Catheter-Product Description 15

Table 14: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 16

Table 15: Lesion Assessment Device-Product Status 16

Table 16: Lesion Assessment Device-Product Description 16

Table 17: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 17

Table 18: BARD HD MESH Mapper Catheter-Product Status 17

Table 19: BARD HD MESH Mapper Catheter-Product Description 17

Table 20: CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 18

Table 21: Khelix Fixed Catheter-Product Status 18

Table 22: Khelix Fixed Catheter-Product Description 18

Table 23: Khelix Fixed Loop EP Catheter-Product Status 19

Table 24: Khelix Fixed Loop EP Catheter-Product Description 19

Table 25: Khelix Fixed Loop Steerable EP Catheter-Product Status 19

Table 26: Khelix Fixed Loop Steerable EP Catheter-Product Description 20

Table 27: Khelix Steerable Catheter-Product Status 20

Table 28: Khelix Steerable Catheter-Product Description 20

Table 29: Khelix Variable Loop Steerable EP Catheter-Product Status 21

Table 30: Khelix Variable Loop Steerable EP Catheter-Product Description 21

Table 31: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 22

Table 32: EP Lesion Assessment Device-Product Status 22

Table 33: EP Lesion Assessment Device-Product Description 22

Table 34: Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview 23

Table 35: Fibrillation Catheter-Product Status 23

Table 36: Fibrillation Catheter-Product Description 23

Table 37: King's College London Pipeline Products & Ongoing Clinical Trials Overview 24

Table 38: Steerable Catheter-Product Status 24

Table 39: Steerable Catheter-Product Description 24

Table 40: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 25

Table 41: Circular Diagnostic Catheter-Product Status 25

Table 42: Circular Diagnostic Catheter-Product Description 26

Table 43: EasyFinder Fixed Curve Diagnostic Catheter-Product Status 26

Table 44: EasyFinder Fixed Curve Diagnostic Catheter-Product Description 26

Table 45: EasyLoop-Variable Loop-Product Status 27

Table 46: EasyLoop-Variable Loop-Product Description 27

Table 47: The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview 28

Table 48: EP Mapping Catheter-Product Status 28

Table 49: EP Mapping Catheter-Product Description 28

Table 50: University of Maryland Pipeline Products & Ongoing Clinical Trials Overview 29

Table 51: Steerable Actuated Catheter-Product Status 29

Table 52: Steerable Actuated Catheter-Product Description 29

Table 53: Glossary 65

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022